Interview Guidance Program (IGP) for UPSC CSE 2024, Registrations Open Click Here to know more and registration
Source: Indian Express
What is the news?
A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute (IVI) in partnership with Bharat Biotech International Ltd (BBIL) has begun in Costa Rica.
| Read more: World may soon get a vaccine against Chikungunya |
What is Chikungunya?
It is a viral disease transmitted to humans by infected mosquitoes
How is it transmitted?
Chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes. These are the same mosquitoes that transmit the dengue virus.
Symptoms:
- The most common symptoms of infection are fever and joint pain
- Other symptoms may include headache, muscle pain, joint swelling, or rash.
Vaccination: Presently, there is no vaccine to prevent or medicine to treat Chikungunya virus infection.
Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants
Subscribe to get the latest posts sent to your email.
